Starting in 2020 medtech firms will be competing in a significantly more complicated European market. New Medical Devices Regulations (MDR) were written to strengthen device safety standards but they will make it far more onerous and expensive for medtech firms to market their products in Europe. Because of the MDR, many smaller companies may not be able to comply, and …
Novartis, Abbott, GE, Siemens, and Other Healthcare Giants Are Reversing Previous Diversification Strategies
Novartis/Alcon After assessing strategic options for Alcon, Novartis is spin-ning it out to shareholders. As a result, both companies will now rivet on their core strengths –pharmaceuticals and oph-thalmic devices, respectively. When Novartis acquired Alcon in 2011 for $52b, the business included surgical, vision care and ophthalmic pharmaceuticals. In 2016, Novartis absorbed Alcon’s drug business, leaving Alcon as pure …
Sivantos and Widex Announce Merger
Sivantos, a Germany-based hearing aid maker previously owned by Siemens will merge with Widex, a Denmark-based hearing aid maker to form a company with an enterprise value of more than $8b. Sivantos, owned by EQT Partners, and Widex are merging to form the 3rd largest hearing aid maker. The merger will likely push back EQT’s plans for an IPO of Sivantos by a few years, …
As part of J&J’s de-diversifying, it is selling its Advanced Sterilization Products (ASP) business to Fortive Corportion (a Danaher spinout)
Fortive Corporation, a $6.86b diversified conglomerate spinout from Danaher, is acquiring Johnson & Johnson’s Advanced Sterilization Products (ASP) business for $2.8b. ASP provides sterilization and disinfection systems and low-temperature hydrogen peroxide sterilization technology. ASP’s products include the STERRAD system for sterilizing instruments, EVOTECH and ENDOCLENS systems for endoscope reprocessing and cleaning. JNJ sold approximately $2.1b of both units. Last year, JNJ acquired Actelion for …
Boston Scientific Announces Acquisition Of nVision Medical Corporation
Boston Scientific Corporation, a $8.83b manufacturer of medical devices for cardiovascular, digestive, pulmonary and other interventional specialties is acquiring nVision Medical, a developer of a device for collecting cells from the fallopian tubes to detect ovarian cancer. Ovarian cancer is the fifth leading cause of cancer death among women. More than 2 million women in the U.S. are at high risk and it …
Johnson & Johnson Acquired Orthotaxy to Develop a Robotic-Assisted Orthopedic Surgery Solution
With its acquisition of Orthotaxy, Johnson & Johnson joins a growing list of medtech players strengthening surgical robotics offerings expanding the technology’s applications. Orthotaxy’s is in early-stage development for total and partial knee replacement. The deal helps J&J compete more effectively against Stryker’s Mako orthopedic surgical solution, acquired in 2013. In 2015, J&J’s Ethicon unit partnered with Verily, Google’s life sciences unit, to form Verb, …
Roche acquires Flatiron Health for $1.9b
Roche Holding AG, a $54.1b research-focused, biotechnology company is acquiring Flatiron Health, a developer of an OncologyCloud platform which includes medical record for oncology, advanced analytics, patient portal and integrated billing for $1.9b. Flatiron’s cancer-centric electronic health records platform is connected to about 250 community oncology practices; it has a partnership with the National Cancer Institute (NCI), a part of the National Institutes …
Allergan to Acquire Elastagen’s Next Generation Injectable Portfolio for $95m
Allergan Plc, a $15.9b provider of medical aesthetics, biosimilars, and over-the-counter pharmaceutical products will acquire Elastagen Pty Ltd., a provider of advanced tissue repair platform based on tropoelastin (gives tissue its elasticity) for $95m. The acquisition adds proprietary injectable products to Allergan’s existing portfolio. Elastagen’s technology is based on human tropoelastin, the precursor of elastin which is a key component of youthful skin. …
Boston Scientific Corporation acquires Millipede, Inc. for $90m
Boston Scientific Corporation, a $8.83b manufacturer of medical devices for cardiovascular, digestive, pulmonary and other interventional specialties is acquiring Millipede, Inc., a developer of transcatheter, semi-rigid, complete annuloplasty ring for the treatment of heart disease for $90m. Millipede IRIS’ annuloplasty ring which is delivered via a transcatheter-transseptal delivery system repairs and reduce the size of a dilated mitral annulus. The IRIS device is a …
Wright Medical Group N.V acquires Imascap SAS
Wright Medical Group N.V, a $720.4m developer of specialty orthopedics focused on extremity and biologic solutions is acquiring Imascap SAS, a developer preoperative planning of shoulder replacement surgery software for $62.50m plus $26.30m in milestones. The deal accelerates Wright Medical’s product portfolio and leverages its extremities business. IMASCAP’s Glenosys technology allows surgeon to simulate the position of a shoulder prosthesis using CT image …